BHCM
JNJ icon

Brevan Howard Capital Management’s Johnson & Johnson JNJ Stock Holding History

Brevan Howard Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-80,000
Closed -$7.33M – 23
2013
Q4 		$7.33M Hold
80,000
– – 2.55% 12
2013
Q3 		$6.93M Hold
80,000
– – 3.24% 14
2013
Q2 		$6.87M Buy
+80,000
New +$6.79M 1.2% 15

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brevan Howard Capital Management's JNJ Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Johnson & Johnson (JNJ) stake by 67% in Q1 2026, selling an estimated $8.52M and leaving 18,431 shares worth $4.51M. The position accounts for 0.04% of the portfolio, ranked #272.

Brevan Howard Capital Management first reported a position in JNJ in Q2 2013 and has held it in 11 quarters since. The position peaked at $21.6M in Q2 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Brevan Howard Capital Management held 18,431 shares of Johnson & Johnson worth $4.51M as of Q1 2026.
  • Brevan Howard Capital Management sold 36,591 Johnson & Johnson shares in Q1 2026, an estimated $8.52M.
  • Johnson & Johnson made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #272 holding.
  • Brevan Howard Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Johnson & Johnson position peaked at $21.6M in Q2 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.